19 May 2013
Keywords: Hospira, Gemcitabine, Gemzar, Eli Lilly
Article | 07 August 2011
US generic injectable drug leader Hospira (NYSE: HSP) says the US Food and Drug Administration has approved its gemcitabine injection, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 August 2011
8 August 2011
17 May 2013
© 2013 thepharmaletter.com